NR4A1 and neoplasm: In breast cancer, the expression of hormone receptors on tumours plays an integral role in determining both tumour character and accordingly patient prognosis, with tumours responding to anti-hormonal agents having a significantly more favourable outlook than those that are hormone receptor negative [129,130].